Caribou Biosciences Inc (NASDAQ:CRBU) price on current trading day, rose 13.35% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.90.
A look at the stock’s price movement, the close in the last trading session was $0.79, moving within a range at $0.765 and $0.9799. The beta value (5-Year monthly) was 2.362. Turning to its 52-week performance, $4.59 and $0.66 were the 52-week high and 52-week low respectively. Overall, CRBU moved -16.31% over the past month.
Caribou Biosciences Inc’s market cap currently stands at around $83.28 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-09.
The average forecast suggests down to a -40.72% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 8.58M, representing a -14.19% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRBU is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CRBU as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRBU’s current price about -2.43% and -20.70% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.80, while 7-day volatility ratio is 15.50% and 10.99% in the 30-day chart. Further, Caribou Biosciences Inc (CRBU) has a beta value of 2.18, and an average true range (ATR) of 0.10. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -233.33% off current price level while to achieve the yearly target high, price needs to move -233.33%. Nonetheless, investors will most likely welcome a -233.33% jump to $3 which is the analysts’ median price.
If we refocus on Caribou Biosciences Inc (NASDAQ:CRBU), historical trading data shows that trading volumes averaged 1.15 over the past 10 days and 1.22 million over the past 3 months. The company’s latest data on shares outstanding shows there are 92.38 million shares.
The 13.11% of Caribou Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 59.13% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.82 million on 2025-03-14, giving us a short ratio of 8.49. The data shows that as of 2025-03-14 short interest in Caribou Biosciences Inc (CRBU) stood at 993.00005 of shares outstanding, with shares short falling to 8.91 million registered in 2025-02-14. Current price change has pushed the stock -43.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRBU stock continues to rise going into the next quarter.
